GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (BOM:532878) » Definitions » EV-to-Revenue

Alpa Laboratories (BOM:532878) EV-to-Revenue : 0.59 (As of May. 29, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Alpa Laboratories EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Alpa Laboratories's enterprise value is ₹671 Mil. Alpa Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1,143 Mil. Therefore, Alpa Laboratories's EV-to-Revenue for today is 0.59.

The historical rank and industry rank for Alpa Laboratories's EV-to-Revenue or its related term are showing as below:

BOM:532878' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.34   Med: 0.8   Max: 3.99
Current: 0.58

During the past 13 years, the highest EV-to-Revenue of Alpa Laboratories was 3.99. The lowest was -0.34. And the median was 0.80.

BOM:532878's EV-to-Revenue is ranked better than
87.18% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 2.315 vs BOM:532878: 0.58

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-29), Alpa Laboratories's stock price is ₹82.72. Alpa Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹54.37. Therefore, Alpa Laboratories's PS Ratio for today is 1.52.


Alpa Laboratories EV-to-Revenue Historical Data

The historical data trend for Alpa Laboratories's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpa Laboratories EV-to-Revenue Chart

Alpa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 -0.17 0.35 0.74 0.37

Alpa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.53 0.37 1.57 0.41 1.90

Competitive Comparison of Alpa Laboratories's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpa Laboratories's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Alpa Laboratories's EV-to-Revenue falls into.



Alpa Laboratories EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Alpa Laboratories's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=670.513/1142.648
=0.59

Alpa Laboratories's current Enterprise Value is ₹671 Mil.
Alpa Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,143 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpa Laboratories  (BOM:532878) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Alpa Laboratories's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=82.72/54.37
=1.52

Alpa Laboratories's share price for today is ₹82.72.
Alpa Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹54.37.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpa Laboratories EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Alpa Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpa Laboratories (BOM:532878) Business Description

Traded in Other Exchanges
Address
33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the business segment of Drugs and Chemicals. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.

Alpa Laboratories (BOM:532878) Headlines

No Headlines